The potential of the novel NAD+ supplementing agent, SNH6, as a therapeutic strategy for the treatment of Friedreich's ataxia.

Autor:	Chiang, Shannon1 (AUTHOR), Kalinowski, Danuta S.1 (AUTHOR), Dharmasivam, Mahendiran1 (AUTHOR), Braidy, Nady2 (AUTHOR), Richardson, Des R.1,3 (AUTHOR) d.richardson@sydney.edu.au, Huang, Michael L.H.1 (AUTHOR) michael.huang@sydney.edu.au
Zdroj:	Pharmacological Research. May2020, Vol. 155, pN.PAG-N.PAG. 1p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect